Eikon Therapeutics, Inc. (EIKN)
NASDAQ: EIKN · Real-Time Price · USD
8.60
+0.04 (0.47%)
Apr 29, 2026, 9:50 AM EDT - Market open
Eikon Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Market Capitalization | 466 | - | - | - |
| Enterprise Value | 385 | - | - | - |
| Debt / Equity Ratio | 0.91 | 0.91 | 0.86 | 0.07 |
| Net Debt / Equity Ratio | -0.28 | -0.28 | -0.07 | -0.85 |
| Net Debt / EBITDA Ratio | 0.27 | 0.27 | 0.07 | 1.57 |
| Net Debt / FCF Ratio | 0.33 | 0.33 | 0.08 | 1.82 |
| Quick Ratio | 6.11 | 6.11 | 3.90 | 13.69 |
| Current Ratio | 6.34 | 6.34 | 4.04 | 13.88 |
| Return on Equity (ROE) | -125.02% | -125.02% | -69.35% | - |
| Return on Assets (ROA) | -36.19% | -36.19% | -32.00% | - |
| Return on Capital Employed (ROCE) | -58.30% | -58.30% | -59.90% | -53.80% |
| Buyback Yield / Dilution | - | -14.85% | -24.35% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.